Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01977729 · ClinicalTrials.gov registry record · Phase 2
Sequencing CBT for Child Anxiety: CBT Plus Sertraline Versus Switch to Sertraline
A Phase 2 study, sponsored by Yale University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01977729 is a Phase 2 study that was terminated before completion, run by Yale University. The registered enrollment target is 1 participants.
The verdict
NCT01977729, a Phase 2 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cognitive behavioral therapy (CBT) in combination with sertraline (SRT) is more effective than SRT alone in treating children and adolescents with anxiety disorders (after an initial 8 weeks of CBT).
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01977729
The ClinicalTrials.gov registry entry for NCT01977729 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01977729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01977729 about?
NCT01977729 is a clinical study titled "Sequencing CBT for Child Anxiety: CBT Plus Sertraline Versus Switch to Sertraline". The purpose of this study is to determine whether cognitive behavioral therapy (CBT) in combination with sertraline (SRT) is more effective than SRT alone in treating children and adolescents with anxiety disorders (after an initial 8 weeks of CBT).
What is the current status of trial NCT01977729?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2013-10. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01977729?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Sertraline (DRUG).
Who is sponsoring clinical trial NCT01977729?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.